Back to search

Article

Molecular & Translational Biology of the Blood-Based VeriStrat® Proteomic Test Used in Cancer Immunotherapy Treatment Guidance

2022-12-30

Abstract excerpt

<h4>INTRODUCTION</h4> The blood-based VeriStrat ® proteomic test (VS) predicts patient response to therapy based on the intensities of eight different features in a mass spectrum obtained from MALDI-TOF analysis of human serum/plasma specimens. An interim analysis of the INSIGHT clinical trial ( NCT03289780 ) demonstrated that VS labels, VS Good and VS Poor, predict patients with non-small cell lung cancer (NSCLC)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9f15a85f-e9cf-5af1-a784-3b543c161020
DOI
10.1101/2022.12.28.22283689
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular & Translational Biology of the Blood-Based VeriStrat® Proteomic Test Used in Cancer Immunotherapy Treatment GuidanceDOI 10.1101/2022.12.28.22283689
Bioinformatics analysis of NSCLC multi-omics dataSemantic proximity
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapySemantic proximity
Sensitive and Specific Early-Stage Breast Cancer Detection using Deep Proteome Profiling from PlasmaSemantic proximity
Plasma proteome-based test (PROphetNSCLC) predicts response to immune checkpoint inhibitors (ICI) independent of tumor programmed death-ligand 1(PD-L1) expression and tumor mutational burden (TMB)Semantic proximity
A novel decision-making tool for first-line treatment selection in metastatic non-small cell lung cancer based on plasma proteome profilingSemantic proximity
Decoding the Circulating Proteome: Matrix and Immune Context Markers Shape Early Multi-Cancer DetectionSemantic proximity
Profiling Protein Post-Translational Modifications in Plasma-derived Extracellular Vesicles as Fingerprints for Breast Cancer SubtypesSemantic proximity
Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancersSemantic proximity
Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target SelectionSemantic proximity
Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypesSemantic proximity
Quantitative mass spectrometry to interrogate proteomic heterogeneity in metastatic lung adenocarcinoma and validate a novel somatic mutation CDK12-G879VSemantic proximity
A Single-Aliquot, Enrichment-Free Workflow for High-Throughput Plasma Proteome and N-Glycoproteome ProfilingSemantic proximity
Select a neighboring publication to make it the new centre.